ロード中...
Metastatic Thymoma Harboring a Deleterious BRCA2 Mutation Derives Durable Clinical Benefit from Olaparib
Thymomas comprise a group of rare epithelial neoplasms of the anterior mediastinum. Whereas localized disease carries a favorable prognosis, the majority of patients with metastatic thymomas experience progression or recurrence over a 10‐year period. Although targeted therapies have become standard...
保存先:
| 出版年: | Oncologist |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley & Sons, Inc.
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7160398/ https://ncbi.nlm.nih.gov/pubmed/32297440 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0393 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|